10.1111/cas.14457 95 SchaverienM
Responsible prescribing starts with determining whether the treatment aligns with your individual health profile
To date, liraglutide, and the more effective once-weekly semaglutide, have been approved in the US and Europe for the treatment of obesity, with unprecedented weight loss of up to 1520%
12 In addition, propionate is an end-product of fermentation and thus is not cross-metabolised by the microbiota unlike acetate and butyrate
These medications work with natural hormone pathways involved in hunger regulation and blood sugar control
Programs that offer subscription-based medication services often cost upwards of $300 per month, and these non-FDA approved compounded GLP-1 medications raise serious concerns due to variability in dosage, potential for harmful additives, and lack of rigorous safety and efficacy testing